Skip to main content

Abstract

Like many therapies, the treatment of prostate cancer has evolved over the years. While the radical prostatectomy began as the initial curative treatment, it was associated with significant co-morbidities that greatly affected a patient’s quality of life. The improvement in surgical technique and improved description of the anatomy has led to significant improvements in the outcomes. Advances in irradiation techniques have also added to the options a patient has to consider when deciding on a treatment for his prostate cancer. Treatments have continued to improve to become less invasive and less impactful on a patient’s quality of life. However, to date, the options all have very similar outcomes in regard to cancer control, potency and urinary control, which have been described as the “trifecta” goal of prostate cancer treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Young HH (1905) The early diagnosis and radical cure of carcinoma of the prostate. Johns Hopkins Hosp Bull 16:315–321

    Google Scholar 

  2. Millin T (1945) Retropubic prostatectomy; a new extravesical technique; report of 20 cases. Lancet 2:693–696

    Article  PubMed  CAS  Google Scholar 

  3. Walsh PC, Donker PJ (1982) Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 128:492–497

    PubMed  CAS  Google Scholar 

  4. Walsh PC (2007) The discovery of the cavernous nerves and development of nerve sparing radical retropubic prostatectomy. J Urol 177:1632–1635

    Article  PubMed  Google Scholar 

  5. Kundu SD, Roehl KA, Eggener SE et al (2004) Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol 172:2227–2231

    Article  PubMed  Google Scholar 

  6. Pasteau O, Degrais P (1914) The radium treatment of cancer of the prostate. Arch Roentgen Ray 18:396

    Google Scholar 

  7. Sklar GN, Eddy HA, Jacobs SC et al (1993) Combined antitumor effect of suramin plus irradiation in human prostate cancer cells: the role of apoptosis. J Urol 150:1526–1532

    PubMed  CAS  Google Scholar 

  8. Sogani PC, Whitmore WF Jr, Hilaris BS et al (1980) Experience with interstitial implantation of iodine 125 in the treatment of prostatic carcinoma. Scand J Urol Nephrol Suppl 55:205–211

    PubMed  CAS  Google Scholar 

  9. Blasko JC, Ragde H, Grimm PD (1991) Transperineal ultrasound-guided implantation of the prostate: morbidity and complications. Scand J Urol Nephrol Suppl 137:113–118

    PubMed  CAS  Google Scholar 

  10. Schuessler WW, Kavoussi L, Clayman RV (1992) Laparo­scopic radical prostatectomy: initial case report [abstr 130]. J Urol Suppl 147:246A

    Google Scholar 

  11. Schuessler WW, Schulam PG, Clayman RV et al (1997) Laparoscopic radical prostatectomy: initial short-term experience. Urology 50:854–857

    Article  PubMed  CAS  Google Scholar 

  12. Abbou CC, Salomon L, Hoznek A et al (2000) Laparoscopic radical prostatectomy: preliminary results. Urology 55:630–634

    Article  PubMed  CAS  Google Scholar 

  13. Guillonneau B, Cathelineau X, Barret E et al (1999) Laparoscopic radical prostatectomy: technical and early oncological assessment of 40 operations. Eur Urol 36:14–20

    Article  PubMed  CAS  Google Scholar 

  14. Rassweiler J, Sentker L, Seemann O et al (2001) Heilbronn laparoscopic radical prostatectomy. Technique and results after 100 cases. Eur Urol 40:54–64

    Article  PubMed  CAS  Google Scholar 

  15. Bollens R, Van den Bossche M, Roumeguere T et al (2001) Extraperitoneal laparoscopic radical prostatectomy. Results after 50 cases. Eur Urol 40:65–69

    Article  PubMed  CAS  Google Scholar 

  16. Trabulsi EJ, Guillonneau B (2005) Laparoscopic radical prostatectomy. J Urol 173:1072–1079

    Article  PubMed  Google Scholar 

  17. Menon M, Shrivastava A, Tewari A et al (2002) Laparoscopic and robot assisted radical prostatectomy: establishment of a structured program and preliminary analysis of outcomes. J Urol 168:945–949

    Article  PubMed  Google Scholar 

  18. Ahlering TE, Skarecky D, Lee D et al (2003) Successful transfer of open surgical skills to a laparoscopic environment using a robotic interface: initial experience with laparoscopic radical prostatectomy. J Urol 170:1738–1741

    Article  PubMed  Google Scholar 

  19. Guillonneau B (2003) What robotics in urology? A current point of view. Eur Urol 43:103–105

    Article  PubMed  Google Scholar 

  20. Cooper IS, Lee AS (1961) Cryostatic congelation: a system for producing a limited, controlled region of cooling or freezing of biologic tissues. J Nerv Ment Dis 133:259–263

    Article  PubMed  CAS  Google Scholar 

  21. Baust JG, Gage AA (2005) The molecular basis of cryosurgery. BJU Int 95:1187–1191

    Article  PubMed  Google Scholar 

  22. Gage AA, Baust J (1998) Mechanisms of tissue injury in cryosurgery. Cryobiology 37:171–186

    Article  PubMed  CAS  Google Scholar 

  23. Hoffmann NE, Bischof JC (2002) The cryobiology of cryosurgical injury. Urology 60:40–49

    Article  PubMed  Google Scholar 

  24. Onik GM, Cohen JK, Reyes GD et al (1993) Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 72:1291–1299

    Article  PubMed  CAS  Google Scholar 

  25. Saliken JC, Donnelly BJ, Rewcastle JC (2002) The evolution and state of modern technology for prostate cryosurgery. Urology 60:26–33

    Article  PubMed  Google Scholar 

  26. Bahn DK, Lee F, Badalament R et al (2002) Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 60:3–11

    Article  PubMed  Google Scholar 

  27. Donnelly BJ, Saliken JC, Ernst DS et al (2002) Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology 60:645–649

    Article  PubMed  CAS  Google Scholar 

  28. Ellis DS (2002) Cryosurgery as primary treatment for localized prostate cancer: a community hospital experience. Urology 60:34–39

    Article  PubMed  Google Scholar 

  29. Han KR, Cohen JK, Miller RJ et al (2003) Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol 170:1126–1130

    Article  PubMed  Google Scholar 

  30. Shinohara K (2003) Prostate cancer: cryotherapy. Urol Clin North Am 30:725–736, viii

    Article  PubMed  Google Scholar 

  31. Robinson JW, Donnelly BJ, Saliken JC et al (2002) Quality of life and sexuality of men with prostate cancer 3 years after cryosurgery. Urology 60:12–18

    Article  PubMed  Google Scholar 

  32. Madersbacher S, Pedevilla M, Vingers L et al (1995) Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res 55:3346–3351

    PubMed  CAS  Google Scholar 

  33. Chapelon JY, Ribault M, Vernier F et al (1999) Treatment of localised prostate cancer with transrectal high intensity focused ultrasound. Eur J Ultrasound 9:31–38

    Article  PubMed  CAS  Google Scholar 

  34. Thuroff S, Chaussy C, Vallancien G et al (2003) High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol 17:673–677

    Article  PubMed  Google Scholar 

  35. Uchida T, Nitta M, Hongo S et al (2007) High-intensity focused ultrasound for the treatment in 503 patients with localized prostate cancer. Urology 70:2

    Article  Google Scholar 

  36. Bentzen SM, Ritter MA (2005) The alpha/beta ratio for prostate cancer: what is it, really? Radiother Oncol 76:1–3

    Article  PubMed  Google Scholar 

  37. King CR, Fowler JF (2001) A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low. Int J Radiat Oncol Biol Phys 51:213–214

    PubMed  CAS  Google Scholar 

  38. King CR, Lehmann J, Adler JR et al (2003) CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility. Technol Cancer Res Treat 2:25–30

    PubMed  Google Scholar 

  39. Madsen BL, Hsi RA, Pham HT et al (2007) Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. Int J Radiat Oncol Biol Phys 67:1099–1105

    Article  PubMed  Google Scholar 

  40. Freeman DE, King CR (2011) Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes. Radiat Oncol 6:3

    Article  PubMed  Google Scholar 

  41. King CR, Brooks JD, Gill H et al (2011) Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer. Int J Radiat Oncol Biol Phys 2011 Feb. 5 (Epub Ahead of print)

    Google Scholar 

  42. Allaf ME, Carter H (2005) The results of watchful waiting for prostate cancer. AUA Update Series 24:1–7

    Google Scholar 

  43. Fowler FJ Jr, McNaughton Collins M, Albertsen PC et al (2000) Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 283:3217–3222

    Article  PubMed  Google Scholar 

  44. Carter HB, Walsh PC, Landis P et al (2002) Expectant management of nonpalpable prostate cancer with curative intent: preliminary results. J Urol 167:1231–1234

    Article  PubMed  Google Scholar 

  45. Johansson JE (1994) Expectant management of early stage prostatic cancer: Swedish experience. J Urol 152:1753–1756

    PubMed  CAS  Google Scholar 

  46. Klotz L (2005) Active surveillance for prostate cancer: for whom? J Clin Oncol 23:8165–8169

    Article  PubMed  Google Scholar 

  47. Choo R, Klotz L, Danjoux C et al (2002) Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol 167:1664–1669

    Article  PubMed  Google Scholar 

  48. Lu-Yao GL, Yao SL (1997) Population-based study of long-term survival in patients with clinically localised prostate cancer. Lancet 349:906–910

    Article  PubMed  CAS  Google Scholar 

  49. Bill-Axelson A, Holmberg L, Ruutu M et al (2005) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352:1977–1984

    Article  PubMed  CAS  Google Scholar 

  50. Warlick C, Trock BJ, Landis P et al (2006) Delayed versus immediate surgical intervention and prostate cancer outcome. J Natl Cancer Inst 98:355–357

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ponsky, L.E., Vricella, G. (2012). Prostate Surgery and the Evolution to Minimally Invasive Therapies. In: Ponsky, L., Fuller, D., Meier, R., Ma, C. (eds) Robotic Radiosurgery. Treating Prostate Cancer and Related Genitourinary Applications. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11495-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-11495-3_5

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-11494-6

  • Online ISBN: 978-3-642-11495-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics